Atıf Formatları
Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

O. K. YÜCEL Et Al. , "Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia," CHEMOTHERAPY , vol.65, no.5-6, pp.166-170, 2021

YÜCEL, O. K. Et Al. 2021. Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia. CHEMOTHERAPY , vol.65, no.5-6 , 166-170.

YÜCEL, O. K., ALEMDAR, M. S., ATAŞ, Ü., & ÜNDAR, L., (2021). Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia. CHEMOTHERAPY , vol.65, no.5-6, 166-170.

YÜCEL, ORHAN Et Al. "Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia," CHEMOTHERAPY , vol.65, no.5-6, 166-170, 2021

YÜCEL, ORHAN K. Et Al. "Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia." CHEMOTHERAPY , vol.65, no.5-6, pp.166-170, 2021

YÜCEL, O. K. Et Al. (2021) . "Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia." CHEMOTHERAPY , vol.65, no.5-6, pp.166-170.

@article{article, author={ORHAN KEMAL YÜCEL Et Al. }, title={Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia}, journal={CHEMOTHERAPY}, year=2021, pages={166-170} }